Background The aetiology of ischaemic heart disease (IHD) is complex and is influenced by a spectrum of environmental factors and susceptibility genes. Traditional statistical modelling considers such factors to act independently in an additive manner. The Patient Rule-Induction Method (PRIM) is a multi-model building strategy for evaluating risk attributable to context-dependent gene and environmental effects. Methods PRIM was applied to 9073 participants from the prospective Copenhagen City Heart Study (CCHS). Gender-specific cumulative incidences were estimated for subgroups defined by categories of age, smoking, hypertension, diabetes, body mass index, total cholesterol, high-density lipoprotein cholesterol and triglycerides and by 94 single nucleotide variants (SNVs).Cumulative incidences for subgroups were validated using an independently ascertained sample of 58 240 participants from the Copenhagen General Population Study (CGPS). Results In the CCHS the overall cumulative incidences were 0.17 in women and 0.21 in men. PRIM identified six and four mutually exclusive subgroups in women and men, respectively, with cumulative incidences of IHD ranging from 0.02 to 0.34. Cumulative incidences of IHD generated by PRIM in the CCHS were validated in four of the six subgroups of women and two of the four subgroups of men in the CGPS. Conclusions PRIM identified high-risk subgroups characterized by specific contexts of selected values of traditional risk factors and genetic variants. These subgroups were validated in an independently ascertained cohort study. Thus, a multi-model strategy may
Introduction
Ischaemic heart disease (IHD) is the leading cause of morbidity and mortality worldwide. 1 The aetiology of IHD is complex and is influenced by a spectrum of environmental factors and susceptibility genes. 2 Traditional statistical modelling considers such factors to act independently in an additive manner, and assumes that the expected relationship between disease status and variation in genetic and environmental risk factors is the same for all individuals in the population under study. This perspective does not take into account the fact that the effects of a particular genetic variant on an individual's risk of disease may depend on context, defined by established environmental risk factors, and by the background genotype. 3, 4 Currently, over 1800 genome-wide association studies (GWAS) have reported validated associations between common single nucleotide variants (SNVs) and complex disorders including cardiovascular disease, cancer, diabetes and psychiatric diseases [(http//:www.genome.gov/gwasstudies]. As these diseases are common, they place the greatest public health burden on society. 4 However, in every case substantial heritable variation in risk of disease and in biological risk factors for disease is not explained by common SNVs identified by the GWAS. 2, [5] [6] [7] [8] Possible explanations for this 'missing heritability' include rare variant effects, the effects of gene-gene and gene-environment interactions, and aetiological heterogeneity (i.e. different combinations of genes and environments influence risk in different subgroups of the population) that are not considered by GWAS. 5, 9 The systematic mapping of regions of transcription, transcription factor association, chromatin structure and histone modification, recently published by the Encyclopedia of DNA Elements (ENCODE) project, revealed that the function of the human transcriptional regulatory network is highly context-specific. 10, 11 Analytical strategies to investigate the context-dependent effects of genomic variations on the risk of a common disease having a complex multifactorial aetiology are currently in their infancy. 2, 5, 9 The Patient Rule-Induction method (PRIM) [12] [13] [14] [15] is a model-building strategy for evaluating risk that acknowledges context-dependent gene and environmental effects and aetiological heterogeneity whereby different combinations of genetic and environmental risk factors are predictive of disease outcome in different genetic and environmentally defined subgroups of the population. This strategy makes possible the identification of combinations of risk factor values, environmental strata and/or genetic variants that characterize mutually exclusive subgroups of individuals that differ in average risk as measured by the cumulative incidence of the disease of interest. In this paper we consider traditional IHD risk factors and 94 SNVs in 22 candidate genes in an application of PRIM to modelling the cumulative incidence of IHD in subgroups of a population-based sample of 9073 individuals enrolled in the prospective Copenhagen City Heart Study (CCHS). We validated the resultant models in an independently ascertained cohort of 58 240 individuals from the Copenhagen General Population Study (CGPS). 
The Copenhagen General Population Study (CGPS)
This is a prospective study of the Danish general population initiated in 2003 with ongoing enrolment. [16] [17] [18] Data were obtained from a questionnaire, a physical examination and blood samples including DNA extraction. We included 58 240 participants with complete clinical and laboratory data available and with no prior history of IHD. Follow-up began at study entry and ended at the occurrence of an IHD event, death, emigration or on 10 May 2010 (last update of registry), whichever came first. Follow-up was up to 7 years, and was 100% complete, i.e. none was lost to follow-up. We used this sample to validate the context-dependent models estimated using the CCHS sample.
Definition of disease endpoint
Information on diagnoses of IHD (WHO International Classification of Diseases, ICD8:410-414; ICD10:I20-I25) was collected from 1977 through 2010 by reviewing all hospital admissions and diagnoses entered in the national Danish Patient Registry and all causes of death entered in the national Danish Causes of Death Registry as described. [16] [17] [18] Ischaemic heart disease was defined by fatal or non-fatal myocardial infarction or characteristic symptoms of angina pectoris, including revascularization procedures, 20 as detailed in international guidelines.
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Laboratory analyses
Total cholesterol, high-density lipoprotein (HDL) cholesterol and triglycerides were measured by colourimetric assays (Boehringer Mannheim GmbH, Mannheim, Germany, and Konelab, Helsinki, Finland).
Genotyping
Genotyping was by TaqMan assays using the ABI PRISM 7900HT Sequence Detection System (Applied Biosystems, Foster City, CA, USA) or by restriction enzyme assays. Genotypes were verified by genotyping at least 50 randomly selected samples of each variant by two different methods (TaqMan assays plus sequencing or restriction enzyme assay); there was 100% agreement between TaqMan and sequencing/restriction enzyme assay results. Call rates for genotypes were above 99.9% for all assays, due to reruns.
Definitions of traditional risk factors
Age was stratified in three groups, <45, 45-65 and !65 years. The definitions of smoking, hypertension and diabetes have been described previously. 12 In brief, each risk factor was dichotomized to define a high-risk group; a history of smoking (current smoker at any examination), a history of hypertension (systolic blood pressure !140 mmHg, diastolic blood pressure !90 mmHg, use of antihypertensive drugs, or any combination of these at any examination) or a history of diabetes (self-reported disease, use of insulin, use of oral hypoglycaemic drugs, non-fasting plasma glucose !11.1 mmol/l at any examination We applied PRIM to obtain risk factor models for mutually exclusive subgroups of risk separately for women and men from the CCHS. We then applied these models of risk to the prediction of IHD in the CGPS sample to evaluate the validation of the models.
Validation analyses
A direct comparison of the value of the cumulative risk estimated for each subgroup modelled by PRIM using the CCHS sample with the observed cumulative incidence for the corresponding subgroup in the CGPS is inappropriate because the samples have different overall cumulative incidences (21.0% in men and 16.7% in women for CCHS and 3.2% in men and 1.9% in women for CGPS). Therefore, we rescaled the estimate of the cumulative incidence of each subgroup predicted by the PRIM models as a deviation from the cumulative incidence in the total sample divided by the cumulative incidence in the total sample. The computed confidence intervals were likewise rescaled.
Rescaling was necessary to adjust for differences in IHD incidence in the training and validation data sets to allow for meaningful evaluation of the prediction models created. We used this percent change metric rather than an odds ratio or relative risk to better manage the boundary effects that exist with odds ratios or relative risk computations. We used the same rescaling transformation for the observed cumulative incidence for each subgroup in the CGPS defined by PRIM analysis of the CCHS sample. If the rescaled observed cumulative incidence in the CGPS subgroup, defined by the PRIM modelling of the CCHS sample, falls within the 95% rescaled predicted confidence interval for the estimate of the cumulative incidence for the subgroup in the CCHS sample, we concluded that the subgroup was validated.
Results
Characteristics
Characteristics of the 5151 women and 3922 men from the Copenhagen City Heart Study are shown in Table 1 . The distribution of individuals in categories of age, smoking, hypertension, diabetes, body mass index, total cholesterol, HDL cholesterol and triglycerides as well as cumulative incidences of IHD differed as a function of gender (Table 1) . Men were more frequently smokers, hypertensives or diabetics, and more frequently had body mass index !25 kg/ m 2 , HDL cholesterol <1.04 mmol/l (40 mg/dl) and triglycerides !1.70 mmol/l (150 mg/dl) compared with women. Women more frequently had total cholesterol !5.18 mmol/l (200 mg/dl) compared with men (v 2 : P <0.0001). These differences in the cumulative incidence of IHD and the frequencies of risk factors between genders justify carrying out model-building separately in women and men. À14.6 to À10.5
Smoking, current-smoker at any examination; hypertension, systolic blood pressure !140 mmHg, diastolic blood pressure !90 mmHg, use of antihypertensive drugs, or any combination of these at any examination; diabetes, self-reported disease, use of insulin, use of oral hypoglycaemic drugs, non-fasting plasma glucose !11.1 mmol/l, or any combination of these at any examination. Body mass index was categorized according to World Health Organization definitions. Recommendations of the National Cholesterol Education Program Expert Panel, National Institutes of Health, were used to define dyslipidaemic subgroups (National Cholesterol Education Program, National Heart, Lung, and Blood Institute 2002). To convert total cholesterol and HDL cholesterol to mg/dl, divide by 0.0259; to convert triglycerides to mg/dl, divide by 0.0113. HDL, high-density lipoprotein; IHD, ischaemic heart disease.
*P-value using v 2 tests. **The confidence interval (CI) for the difference in risk factor frequencies between women and men is calculated using the normal approximation to the binomial distribution. 
Candidate genetic variants
PRIM-defined subgroups from the CCHS sample
The risk factor categories (see Methods) were simultaneously considered with the 94 SNVs (Table 2) in building subgroups using the PRIM in each gender separately. Five and three mutually exclusive subgroups were defined in women and men, respectively, as well as a final remainder subgroup for each gender.
In the sample of women, the cumulative incidences of IHD in the five sequentially identified subgroups and one final remainder subgroup (summarized in Figure 1 ) were: 0.31 [95% confidence interval (CI): 0.28-0.34] for age !65 years and LIPC N193S AGþGG and hypertension; 0.23 (95% CI: 0.21-0.25) for age !65 or diabetes; 0.15 (95% CI: 0.13-0.18) for hypertension and age <65 years and no diabetes; 0.12 (95% CI: 0.09-0.15) for triglycerides !1.70 mmol/l (150 mg/dl) and age <65 years and no diabetes and no hypertension; 0.12 (95% CI: 0.07-0.15) for age 45-64 years and smoking and triglycerides <1.70 mmol/l (150 mg/dl) and no diabetes and no hypertension; and 0.02 (95% CI: 0.02-0.04) for the remainder subgroup.
In the sample of men, the cumulative incidences of IHD in the three sequentially identified subgroups and one final remainder subgroup (summarized in Figure 2) 
Validation of CCHS subgroups in CGPS
Figures 3 and 4 present the rescaled cumulative incidences and their 95% CIs, for the PRIM subgroups of the CCHS samples of women and men, respectively, shown as blue diamonds with confidence intervals. The rescaled cumulative incidences for each of the subgroups in the CGPS sample, defined by the PRIM modelling of the CCHS sample, are denoted by arrows. The PRIM model for IHD risk was validated in four of the six subgroups in women, and in two of the four subgroups in men. Risk was smallest in those subgroups that did not validate. The highest risk in both genders in both samples was associated with subgroups including individuals aged !65 years and with hypertension and/or diabetes. The distribution of risk factor categories among subgroups in CCHS and CGPS is presented in Table 3 for women and in Table 4 for men. The percentage of individuals in the high-risk category was largely comparable between CCHS and CGPS for each subgroup, except for total cholesterol, where individuals in the CCHS more frequently than individuals in the CGPS had total cholesterol !5.18 mmol/l (200 mg/dl).
Discussion
The main finding of the present study is that the PRIM identifies high-risk subgroups of individuals characterized by selected values of traditional risk factors and candidate genetic variants. The majority of these subgroups had cumulative incidences of similar relative magnitude in an independently ascertained cohort study of the same population of inference; these findings are novel, and suggest that a multi-model strategy is able to identify groups of individuals characterized by specific contexts with substantially higher risk of IHD than the overall risk for the general population. This result has clinical relevance because such high-risk subgroups may benefit the most from aggressive preventive treatments.
Extensive studies of model organisms have established that the phenotypic effects of single loci are contingent on the contexts defined by other loci (gene-gene interactions) and the history of exposures to environmental influences (gene-environmental interactions). [24] [25] [26] It has been argued that context-dependent genetic effects are the rule rather than the exception in explaining the biological aetiology of a human trait that has a complex multifactorial aetiology. 3 However, the estimation and testing of gene-gene interactions and gene-environmental interactions using traditional statistical methods to model phenotypic variation of such traits has proved to be inappropriate when using non-experimental data collected in population-based studies. 27 This is of special concern in studies of the common human diseases that have a complex multifactorial aetiology. 3, [28] [29] [30] The primary reasons include that: (i) correlations between loci are inherent in non-experimental 
ABCA1, ATP-binding-cassette transporter A1; ACE, angiotensinogen converting enzyme; AGT, angiotensinogen; ANGPTL4, angiopoetin-like4; APOA1, apolipoprotein A1; APOB, apolipoprotein B; APOE, apolipoprotein E; APOJ, apolipoprotein J (clusterin); Chr9, chromosome 9; CLU, clusterin; F5, factor V; F2, factor II (prothrombin); FGB, fibrinogen b polypeptide; HFE, haemochromatosis gene; LIPC, hepatic lipase; ITGB3, integrin beta 3 (platelet glycoprotien IIb/IIIa); LDLR, low-density lipoprotein receptor; LPL, lipoprotein lipase; MTHFR, methylenetetrahydrofolate reductase; PCSK9, proprotein convertase, subtilisin/kexintype 9; SERPINA1, alfa 1-antitrypsin; SOD3, superoxide dismutase 3, extracellular; ZNF202, zinc finger protein 202. Figure 2 . Consecutively identified, mutually exclusive subgroups with decreasing cumulative incidences of ischaemic heart disease using PRIM in men from the Copenhagen City Heart Study. The data set contained 3922 men, with an overall cumulative incidence of ischaemic heart disease of 0.21. The first subgroup was defined by two peeling terms (Age!65 & Hypertension) and one pasting term (Diabetes). The process of producing a new subgroup based on the unassigned individuals from the previous partition continued until all individuals were assigned to a subgroup. The individuals that were not included in any of the subgroups were assigned to the remainder subgroup. IHD, cumulative incidence of ischaemic heart disease. Parentheses after IHD indicate 95% confidence interval for the cumulative incidence. Age is in years. Terms in italics are the result of a paste operation. =, different from. Figure 1 . Consecutively identified, mutually exclusive subgroups with decreasing cumulative incidences of ischaemic heart disease using PRIM in women from the Copenhagen City Heart Study. The data set contained 5151 women, with an overall cumulative incidence of ischaemic heart disease of 0.17. The first subgroup was defined by three peeling terms (Age!65 & LIPC_N193S ¼ GG, AG & Hypertension). The process of producing a new subgroup based on the unassigned individuals from the previous partition continued until all individuals were assigned to a subgroup. The individuals that were not included in any of the subgroups were assigned to the remainder subgroup. IHD, cumulative incidence of ischaemic heart disease; LIPC_N193S ¼ rs6083 variant in the hepatic lipase gene (Table 2 ). Parentheses after IHD indicate 95% confidence interval for the cumulative incidence. Age is in years. Terms in italics are the result of a paste operation. =, different from.
Subgroup 3 Remainder subgroup
observational studies and confound the phenotypic effect of a single locus with phenotypic effects of correlated loci; and (ii) aetiological heterogeneity, i.e. different subsets of interacting genetic and environmental risk factors are responsible for determining the complex trait phenotype in different subgroups of the population at risk. The application of PRIM in our study addresses both of these issues by focusing on estimating the number of subgroups, each with a particular combination of risk factors, that best explains the distribution of risk of IHD in a population-based sample. In this way the resultant PRIM models incorporate the combined influences of context-dependent gene and environmental effects and aetiological heterogeneity. And most important, rather than estimating interactions with standard statistical procedures and focusing on the causes of heritability in the sampled population, this analytical strategy produces combinations of interacting risk factors which may have utility in informing medicine in achieving improved prevention and treatment selection. An even more difficult issue in the characterization of the role of interacting risk factors is the widely accepted practice of validation of a hypothesized prediction model, developed in one study, in subsequent studies of independently ascertained samples from different geographical and ethnically diverse populations. 28 An optimal replicate sample for a test of model validation should be similar to the model-building sample with respect to ethnicity, genetic structure, relative frequencies of risk factors and access to medical care. Our study is unique in addressing these criteria by considering validation in a sample that is representative of the population being studied: the only exception being that the sample ascertained from the CGPS included adjacent geographical regions north and west of the city of Copenhagen from which the CCHS sample was drawn. Ethnic homogeneity was assured through access to information in the national Central Person Register that facilitated the inclusion of individuals whose Danish ancestry was documented by the place of birth of ancestors three generations back. Similar access to medical care was assured by access of all participants to the tax-financed and centrally administered primary, secondary and tertiary care offered by the Danish Health System. Finally, risk factor frequencies were largely comparable for each subgroup between the two studies, with the exception of levels of To compare cumulative incidences between subgroups from two different population samples with different overall cumulative incidences, for each subgroup we used its deviation from the cumulative incidence in the total sample divided by the cumulative incidence in the total sample. Estimates for CCHS are indicated as blue diamonds with 95% confidence intervals, and CGPS estimates appear as red arrows. CCHS, Copenhagen City Heart Study; CGPS, Copenhagen General Population Study; IHD, ischaemic heart disease. Age is in years. Terms in italics are the result of a paste operation. To compare cumulative incidences between subgroups from two different population samples with different overall cumulative incidences, for each subgroup we used its deviation from the cumulative incidence in the total sample divided by the cumulative incidence in the total sample. Estimates for CCHS are indicated as blue diamonds with 95% confidence intervals, and CGPS estimates appear as red arrows. CCHS, Copenhagen City Heart Study; CGPS, Copenhagen General Population Study; IHD, ischaemic heart disease. Age is in years. Terms in italics are the result of a paste operation. Smoking, current-smoker at any examination; hypertension, systolic blood pressure !140 mmHg, diastolic blood pressure !90 mmHg, use of antihypertensive drugs, or any combination of these at any examination; diabetes, self-reported disease, use of insulin, use of oral hypoglycaemic drugs, non-fasting plasma glucose !11.1 mmol/l or any combination of these at any examination. Body mass index was categorized according to World Health Organization definitions. Recommendations of the National Cholesterol Education Program Expert Panel, National Institutes of Health, were used to define dyslipidaemic subgroups (National Cholesterol Education Program, National Heart, Lung, and Blood Institute 2002). To convert total cholesterol and HDL cholesterol to mg/dl, divide by 0.0259; to convert triglycerides to mg/dl, divide by 0.0113. CCHS, Copenhagen City Heart Study; CGPS, Copenhagen General Population Study; HDL, highdensity lipoprotein; IHD, ischaemic heart disease.
total cholesterol most likely explained by the introduction of statins in the mid 1990s and onwards.
Our study has strengths and limitations that deserve consideration. The highest risk in both genders in both samples was associated with subgroups including individuals aged !65 years with hypertension and/or diabetes, thus ensuring meaningful results generated from this model-building method. In further support of the multimodel strategy, cumulative incidences for IHD generated from the PRIM model were validated for most subgroups in a large independent population. The reason for the validation being divergent for female subgroup 5 could be due to a low number of IHD cases in this subgroup. An additional explanation may be that in this particular subgroup, the fraction of women with total cholesterol !5.18 mmol/l (200 mg/dl) was much lower in the CGPS (31.1%) compared with the CCHS (81.6%). The utility of multi-model approaches to improving prediction will depend critically on having model-building and model-validation samples from the same population of inference, as in the present study, because aetiological heterogeneity will be minimal and context will be largely similar. The 94 genetic variants were selected based on previous candidate studies using single-model statistical methods; hence results from these previous studies are not directly comparable to the present findings generated by a multi-model approach. Further, a biological mechanism underlying a potential context-dependent effect of the hepatic lipase (LIPC) N193S variant in high-risk subgroup 1 in women remains unclear. Why only one SNV was selected in the PRIM procedure remains unexplained. This may be attributable to the fact that each of the 94 common SNVs were considered to have small to moderate effect sizes compared with the larger effects of each of the traditional risk factors that defined the partitions. Nevertheless, the present strategy serves as an example for future studies of the combined roles of traditional risk factors and the more extensive genomic information that is becoming widely available in populationbased studies of the common diseases.
In conclusion, our study has shown that a multi-model strategy has utility for identifying subgroups of individuals characterized by specific contexts with substantial higher risk of IHD than the overall risk for the general population. Smoking, current-smoker at any examination; hypertension, systolic blood pressure !140 mmHg, diastolic blood pressure !90 mmHg, use of antihypertensive drugs, or any combination of these at any examination; diabetes, self-reported disease, use of insulin, use of oral hypoglycaemic drugs, non-fasting plasma glucose !11.1 mmol/l or any combination of these at any examination. Body mass index was categorized according to World Health Organization definitions. Recommendations of the National Cholesterol Education Program Expert Panel, National Institutes of Health, were used to define dyslipidaemic subgroups (National Cholesterol Education Program, National Heart, Lung, and Blood Institute 2002). To convert total cholesterol and HDL cholesterol to mg/dl, divide by 0.0259; to convert triglycerides to mg/dl, divide by 0.0113. CCHS, Copenhagen City Heart Study; CGPS, Copenhagen General Population Study. HDL, highdensity lipoprotein; IHD, ischaemic heart disease.
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